BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Zee HH, Jemec GB. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. J Am Acad Dermatol. 2015;73:S23-S26. [PMID: 26470610 DOI: 10.1016/j.jaad.2015.07.047] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 12.4] [Reference Citation Analysis]
Number Citing Articles
1 Calao M, Wilson JL, Spelman L, Billot L, Rubel D, Watts AD, Jemec GBE. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study. PLoS One 2018;13:e0200683. [PMID: 30040827 DOI: 10.1371/journal.pone.0200683] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
2 Damiani G, Mahroum N, Pigatto PDM, Pacifico A, Malagoli P, Tiodorovic D, Conic RR, Amital H, Bragazzi NL, Watad A, Adawi M. The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study. Nutrients 2019;11:E1781. [PMID: 31374976 DOI: 10.3390/nu11081781] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
3 Shavit E, Alavi A, Bechara FG, Bennett RG, Bourcier M, Cibotti R, Daveluy S, Frew JW, Garg A, Hamzavi I, Hoffman LK, Hsaio J, Kirby JS, Lev-Tov H, Martinez E, Micheletti R, Naik HB, Nassif A, Nicholson C, Parks-Miller A, Patel Z, Piguet V, Ramesh M, Resnik B, Sayed C, Schultz G, Siddiqui A, Tan J, Wortsman X, Lowes MA. Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017. Exp Dermatol 2019;28:94-103. [PMID: 30484907 DOI: 10.1111/exd.13849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Vellaichamy G, Dimitrion P, Zhou L, Ozog D, Lim HW, Liao W, Hamzavi IH, Mi QS. Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa. J Invest Dermatol 2021;141:1888-96. [PMID: 33836848 DOI: 10.1016/j.jid.2021.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang M, Chen QD, Xu HX, Xu YM, Chen HJ, Yang BL. Association of hidradenitis suppurativa with Crohn's disease. World J Clin Cases 2021;9:3506-16. [PMID: 34046451 DOI: 10.12998/wjcc.v9.i15.3506] [Reference Citation Analysis]
6 Garcovich S, De Simone C, Giovanardi G, Robustelli E, Marzano AV, Peris K. Post-bariatric surgery hidradenitis suppurativa: a new patient subset associated with malabsorption and micronutritional deficiencies. Clin Exp Dermatol 2019;44:283-9. [PMID: 30144136 DOI: 10.1111/ced.13732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Wolk K, Wenzel J, Tsaousi A, Witte-Händel E, Babel N, Zelenak C, Volk HD, Sterry W, Schneider-Burrus S, Sabat R. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Br J Dermatol 2017;177:1385-93. [PMID: 28256718 DOI: 10.1111/bjd.15424] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
8 Preda-Naumescu A, Ahmed HN, Mayo TT, Yusuf N. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations. Int J Dermatol 2021. [PMID: 33890304 DOI: 10.1111/ijd.15579] [Reference Citation Analysis]
9 van Straalen KR, Verhagen T, Horváth B, Ardon C, Vossen AR, Driessen R, Boer J, Rondags AL, Prens EP, van der Zee HH. Poor interrater reliability of hidradenitis suppurativa phenotypes. Journal of the American Academy of Dermatology 2018;79:577-8. [DOI: 10.1016/j.jaad.2018.02.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ring HC, Bay L, Nilsson M, Kallenbach K, Miller IM, Saunte DM, Bjarnsholt T, Tolker-Nielsen T, Jemec GB. Bacterial biofilm in chronic lesions of hidradenitis suppurativa. Br J Dermatol 2017;176:993-1000. [PMID: 27564400 DOI: 10.1111/bjd.15007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
11 Frew JW, Hawkes JE, Krueger JG. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa. F1000Res 2018;7:1930. [PMID: 30828428 DOI: 10.12688/f1000research.17267.1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 11.3] [Reference Citation Analysis]
12 Prens EP, Lugo-Somolinos AM, Paller AS, Kerdel F, Duan Y, Teixeira HD, Longcore M, Kimball AB. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice. Am J Clin Dermatol 2020;21:579-90. [PMID: 32077014 DOI: 10.1007/s40257-020-00504-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Jiménez-Gallo D, de la Varga-Martínez R, Ossorio-García L, Albarrán-Planelles C, Rodríguez C, Linares-Barrios M. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa. Mediators Inflamm 2017;2017:2450401. [PMID: 28769536 DOI: 10.1155/2017/2450401] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
14 Bosnić D, Žarković B, Barešić M, Zarkovic M, Anić B. Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab. Reumatologia 2016;54:321-5. [PMID: 28115784 DOI: 10.5114/reum.2016.64910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Cazzaniga S, Pezzolo E, Bettoli V, Abeni D, Marzano AV, Patrizi A, Atzori L, Fabbrocini G, Offidani A, Lasagni C, Dini V, Caproni M, Cannavò SP, Naldi L. Characterization of Hidradenitis Suppurativa Phenotypes: A Multidimensional Latent Class Analysis of the National Italian Registry IRHIS. Journal of Investigative Dermatology 2021;141:1236-1242.e1. [DOI: 10.1016/j.jid.2020.08.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Patel ZS, Hoffman LK, Buse DC, Grinberg AS, Afifi L, Cohen SR, Lowes MA, Seng EK. Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected]. Curr Pain Headache Rep 2017;21:49. [PMID: 29094219 DOI: 10.1007/s11916-017-0647-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
17 Vossen ARJV, van Straalen KR, Swagemakers SMA, de Klein JEMM, Stubbs AP, Venter DJ, van der Zee HH, van der Spek PJ, Prens EP. A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance. J Eur Acad Dermatol Venereol 2020;34:2353-61. [PMID: 32078194 DOI: 10.1111/jdv.16310] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
18 Wolk K, Frambach Y, Jacobi A, Wilsmann-Theis D, Phillipp S, Witte-Händel E, Wenzel J, Mössner R, Sabat R. Increased levels of lipocalin 2 in palmoplantar pustular psoriasis. J Dermatol Sci 2018;90:68-74. [PMID: 29395573 DOI: 10.1016/j.jdermsci.2017.12.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
19 Zhou C, Wen GD, Soe LM, Xu HJ, Du J, Zhang JZ. Novel Mutations in PSENEN Gene in Two Chinese Acne Inversa Families Manifested as Familial Multiple Comedones and Dowling-Degos Disease. Chin Med J (Engl) 2016;129:2834-9. [PMID: 27900998 DOI: 10.4103/0366-6999.194648] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
20 Nielsen RM, Lindsø Andersen P, Sigsgaard V, Theut Riis P, Jemec GB. Pain perception in patients with hidradenitis suppurativa. Br J Dermatol 2020;182:166-74. [PMID: 30919930 DOI: 10.1111/bjd.17935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
21 Tavora IG, Bissoli GC, Miot HA, Schmitt JV. Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group. An Bras Dermatol 2019;94:298-303. [PMID: 31365658 DOI: 10.1590/abd1806-4841.20197687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Elkin K, Daveluy S, Avanaki K(. Hidradenitis suppurativa: Current understanding, diagnostic and surgical challenges, and developments in ultrasound application. Skin Res Technol 2020;26:11-9. [DOI: 10.1111/srt.12759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Ring HC, Sigsgaard V, Thorsen J, Fuursted K, Fabricius S, Saunte DM, Jemec GB. The microbiome of tunnels in hidradenitis suppurativa patients. J Eur Acad Dermatol Venereol 2019;33:1775-80. [PMID: 30908704 DOI: 10.1111/jdv.15597] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
24 Jørgensen A, Thomsen S, Ring HC. Clinical phenotypes of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2018;33. [DOI: 10.1111/jdv.15276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Posso-De Los Rios CJ, Sarfo A, Ghias M, Alhusayen R, Hamzavi I, Lowes MA, Alavi A. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018. Exp Dermatol 2019;28:769-75. [PMID: 30924968 DOI: 10.1111/exd.13928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Derruau S, Renard Y, Pron H, Taiar R, Abdi E, Polidori G, Lorimier S. Combining Magnetic Resonance Imaging (MRI) and Medical Infrared Thermography (MIT) in the pre- and peri-operating management of severe Hidradenitis Suppurativa (HS). Photodiagnosis and Photodynamic Therapy 2018;23:9-11. [DOI: 10.1016/j.pdpdt.2018.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
27 Vivar KL, Kruse L. The impact of pediatric skin disease on self-esteem. Int J Womens Dermatol 2018;4:27-31. [PMID: 29872673 DOI: 10.1016/j.ijwd.2017.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
28 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
29 Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis. Front Immunol 2019;10:892. [PMID: 31105704 DOI: 10.3389/fimmu.2019.00892] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
30 Andrade TCPC, Vieira BC, Oliveira AMN, Martins TY, Santiago TM, Martelli ACC. Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015. An Bras Dermatol 2017;92:196-9. [PMID: 28538878 DOI: 10.1590/abd1806-4841.20175588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Frew JW, Hawkes JE, Sullivan-Whalen M, Gilleaudeau P, Krueger JG. Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa. Br J Dermatol 2019;181:566-71. [PMID: 30693478 DOI: 10.1111/bjd.17695] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
32 Naik HB. Importance of Standardized Nomenclature to Advance Hidradenitis Suppurativa Research and Clinical Care. JAMA Dermatol 2021;157:381-3. [PMID: 33688911 DOI: 10.1001/jamadermatol.2020.5466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Frew JW, Singh N, Jiang CS, Vaughan R, Krueger JG. The Impact of Body Mass Index Upon the Efficacy of Adalimumab in Hidradenitis Suppurativa. Front Med (Lausanne) 2021;8:603281. [PMID: 34239882 DOI: 10.3389/fmed.2021.603281] [Reference Citation Analysis]
34 Kimball AB, Crowley JJ, Papp K, Calimlim B, Duan Y, Fleischer AB, Sobell J. Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice. J Eur Acad Dermatol Venereol 2020;34:1302-8. [PMID: 31800124 DOI: 10.1111/jdv.16132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
35 Martorell A, Jfri A, Koster S, Gomez‐palencia P, Solera M, Alfaro‐rubio A, Hueso L, Sanz‐motilva V. Defining hidradenitis suppurativa phenotypes based on the elementary lesion pattern: results of a prospective study. J Eur Acad Dermatol Venereol 2020;34:1309-18. [DOI: 10.1111/jdv.16183] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
36 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. Journal of the American Academy of Dermatology 2020;82:1045-58. [DOI: 10.1016/j.jaad.2019.08.090] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 35.0] [Reference Citation Analysis]
37 Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen M, Guenova E, Dissemond J, Shinkai K, Langan SM. Pyoderma gangrenosum. Nat Rev Dis Primers 2020;6. [DOI: 10.1038/s41572-020-0213-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
38 List EK, Pascual JC, Zarchi K, Nürnberg BM, Jemec GBE. Mast cells in hidradenitis suppurativa: a clinicopathological study. Arch Dermatol Res 2019;311:331-5. [PMID: 30877368 DOI: 10.1007/s00403-019-01910-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Ovadja ZN, Schuit MM, van der Horst CMAM, Lapid O. Inter- and intrarater reliability of Hurley staging for hidradenitis suppurativa. Br J Dermatol 2019;181:344-9. [PMID: 30585304 DOI: 10.1111/bjd.17588] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
40 Thorlacius L, Riis PT, List EK, Christensen R, Jemec GBE. Sub-classification of Hidradenitis suppurativa: a cross-sectional study. Arch Dermatol Res 2020. [PMID: 33089403 DOI: 10.1007/s00403-020-02149-z] [Reference Citation Analysis]
41 Polidori G, Renard Y, Lorimier S, Pron H, Derruau S, Taiar R. Medical Infrared Thermography assistance in the surgical treatment of axillary Hidradenitis Suppurativa: A case report. Int J Surg Case Rep 2017;34:56-9. [PMID: 28359047 DOI: 10.1016/j.ijscr.2017.03.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
42 Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021;35:50-61. [DOI: 10.1111/jdv.16677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 23.0] [Reference Citation Analysis]
43 Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol 2020;16:1019-37. [PMID: 32896186 DOI: 10.1080/17425255.2020.1810233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ring HC, Theut Riis P, Zarchi K, Miller IM, Saunte DM, Jemec GB. Prodromal symptoms in hidradenitis suppurativa. Clin Exp Dermatol 2017;42:261-5. [DOI: 10.1111/ced.13025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
45 Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol 2021;184:133-40. [PMID: 32119111 DOI: 10.1111/bjd.18983] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
46 Boer J. Does obesity cause a distinct phenotype of hidradenitis suppurativa? J Eur Acad Dermatol Venereol 2018;32:e195-6. [DOI: 10.1111/jdv.14707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Magalhães RF, Rivitti-Machado MC, Duarte GV, Souto R, Nunes DH, Chaves M, Hirata SH, Ramos AMC. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology. An Bras Dermatol 2019;94:7-19. [PMID: 31166401 DOI: 10.1590/abd1806-4841.20198607] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
48 Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol 2021;39:240-7. [PMID: 34272017 DOI: 10.1016/j.clindermatol.2020.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Shibuya Y, Morioka D, Nomura M, Zhang Z, Utsunomiya H. Earwax of patients with hidradenitis suppurativa: A retrospective study. Arch Plast Surg 2019;46:566-71. [PMID: 31775210 DOI: 10.5999/aps.2019.00290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Hessam S, Scholl L, Sand M, Schmitz L, Reitenbach S, Bechara FG. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa. JAMA Dermatol 2018;154:330-5. [PMID: 29417136 DOI: 10.1001/jamadermatol.2017.5890] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]